ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study…
MUNICH, April 18, 2026 /PRNewswire/ -- The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that…
The DOORwaY90 study met its prespecified co-primary endpoints, achieving a best overall response rate (ORR) of 99%WOBURN, Mass., April 13,…
KNOXVILLE, Tenn., April 02, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today highlighted newly…
SINGAPORE, April 02, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider…
Study of 400 senior energy and chemicals leaders across 12 countries signals a tipping point: the sector is racing towards…
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetesCARY, N.C. and NEW YORK,…
Peer-reviewed economic analysis finds a combined ESR + CRP testing strategy reduces misdiagnoses and delivers net cost savings compared to…
BANGALORE, India, March 17, 2026 /PRNewswire/ -- Since the advent of artificial intelligence is transforming global mobility and global education…
A global split in confidence: UK adults are most anxious (52%) vs South Korea least (29%), while high-exposure markets like…